Pharmaceuticals - Bangladesh

  • Bangladesh
  • The projected revenue in the Pharmaceuticals market in Bangladesh is expected to reach US$2,277.00m in 2024.
  • Among the various markets, the largest one is Oncology Drugs, which is projected to have a market volume of US$129.90m in 2024.
  • The revenue in the Pharmaceuticals market is expected to demonstrate an annual growth rate (CAGR 2024-2029) of -4.16%, leading to a market volume of US$1,841.00m by 2029.
  • In comparison to other countries worldwide, United States is anticipated to generate the highest revenue of US$630.30bn in 2024.
  • "Bangladesh's pharmaceutical market is experiencing rapid growth, driven by increasing demand for affordable and accessible healthcare solutions."

Key regions: United States, China, Germany, Japan, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

Bangladesh has been experiencing a significant growth in the Pharmaceuticals market in recent years, with an increasing demand for both generic and branded drugs.

Customer preferences:
The customers in Bangladesh tend to prefer locally manufactured drugs, as they are more affordable than imported ones. However, the demand for imported drugs has also been increasing due to the perceived higher quality of these drugs. Additionally, there is a growing demand for specialized drugs, such as those for chronic diseases like diabetes and hypertension.

Trends in the market:
The Pharmaceuticals market in Bangladesh has been growing rapidly due to the increasing population, rising income levels, and government initiatives to improve healthcare. The market has also been boosted by the growth of the middle class, which has led to an increasing demand for healthcare products and services. Moreover, the rise of e-commerce has made it easier for customers to access pharmaceutical products, which has further increased the demand for these products.

Local special circumstances:
One of the special circumstances in Bangladesh is the presence of a large number of unregistered drug manufacturers, which has led to concerns about the quality and safety of drugs. The government has been taking steps to regulate the industry and ensure that only licensed manufacturers are allowed to operate. Additionally, the lack of a proper distribution network has made it difficult for customers to access drugs in remote areas of the country.

Underlying macroeconomic factors:
The growth of the Pharmaceuticals market in Bangladesh is also driven by underlying macroeconomic factors, such as the increasing GDP and rising healthcare expenditure. The government has been investing in healthcare infrastructure and increasing its healthcare budget, which has led to an increase in the availability of drugs and healthcare services. Furthermore, the growth of the Pharmaceuticals market has also created employment opportunities and contributed to the overall economic growth of the country.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)